YD Bio Limited (YDESW)
NGM
$0.25
+13.64%
Closing price as of 2026-07-30 · Source: TEK2day Finance
Key Metrics
Exchange
NGM
Currency
USD
About YD Bio Limited
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Annual Financials
| Metric | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Revenue | 350K | 510K | 597K |
| Gross Profit | 153K | 155K | 167K |
| Operating Income | -7K | -1.5M | -5.3M |
| Net Income | 14K | -1.4M | -8.3M |